Anrukinzumab

DB12294InvestigationalProtein Based Therapies

Anrukinzumab has been used in trials studying the diagnostic of Asthma.

Mechanism
Curator reviewed
Code names
IMA-638

Resolves to

Compound
UNIIOU46IGC49FCAS910649-32-0
Targets
P35225IL13

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Anrukinzumab, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In